Introducing our new product: TOFAZ-5 TAB

TOFAZ-5 TAB.

Composition : Tofacitinib 5 mg.tab.

Packing-10 X 1 X10 Alu-Alu

Mrp.350.00/10 TAB.

Launching date. 04 November  2023

Marketed by- Allenge India (https://www.allengeindia.com/)

                      249, Industrial Area, Phase-2, Panchkula-134109 Haryana

                      For Queries +91 9356560523

                      Email:allengeindia@gmail.com

Tofacitinib is a medication utilized in the management of various autoimmune conditions, particularly rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Functioning as a Janus kinase (JAK) inhibitor, tofacitinib disrupts the activity of Janus kinases, pivotal enzymes in the signaling pathways of inflammatory cytokines. By targeting these pathways, tofacitinib helps to alleviate inflammation and mitigate symptoms associated with autoimmune diseases. Its primary indications include rheumatoid arthritis, especially when other disease-modifying ant rheumatic drugs (DMARDs) have proven ineffective, as well as psoriatic arthritis in patients with inadequate response to alternative therapies. Additionally, it is approved for the treatment of moderate to severe ulcerative colitis in cases where previous treatments have not yielded desired results. Tofacitinib is typically administered orally in tablet form, with dosage and frequency varying based on the specific condition and individual patient response. Common side effects include upper respiratory tract infections, headaches, diarrhea, and hypertension, while more serious risks encompass elevated susceptibility to infections and certain cancers. Regular monitoring, including blood tests to assess liver function, lipid levels, and blood cell counts, is often necessary during treatment. Tofacitinib is contraindicated in patients with a history of severe allergic reactions to the medication or its components and requires caution in individuals with certain pre-existing medical conditions. Overall, while offering promising therapeutic benefits, careful evaluation of risks and benefits, along with diligent patient monitoring, is essential in the use of tofacitinib for autoimmune disorders. 

Common side effects

TOFAZ-5 TAB includes the common side effects like: 

- Upper respiratory tract infections

- Headaches

- Diarrhea

- Hypertension

These side effects are frequently reported in individuals undergoing treatment with tofacitinib. It's important for patients to be aware of these potential side effects and to promptly inform their healthcare provider if they experience any of them during treatment. 

 Similar Products in Indian Markets

1.  Tofakin-5                                                 Lupin Ltd.

2.  Jakura-5                                                  Hetro Drugs ltd.

3.  C Tofa-5                                                 Cucard Pharma

4.  Tofacare-5                                              Care Formulation Lab Pvt. Ltd.

5.  Tofamit-5                                                Mits Healthcare Pvt. Ltd.

To know more about Tofaz-5 Tab. visit our websitewww.allengeindia.com or contact us at allengeindia@gmail.com. You can also call us at +919356560523, or +91 7888602869.